ReviewOncoTargets and therapy2016

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib.

Theresa M Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.